Eli Lilly Settles Zyprexa Investigations for $62 Million
Eli Lilly has settled Zyprexa lawsuits with 32 states and Washington DC, for a reported $62 million, putting an end to investigations into the company's marketing practices of the antipsychotic medication.
According to the attorney general for Indiana, Lilly allegedly marketed the drug for pediatric use, and for use in dementia patients at high doses. While the FDA allows physicians to prescribe drugs off-label, pharmaceutical companies are not allowed to market their drugs for unapproved uses.
The settlement will be divided among the states and Washington DC based on population.
Legal HelpIf you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on Oct-7-08
READ MORE Drugs/Medical Settlements and Legal News